Ralfinamide mesylate

CAS No. 202825-45-4

Ralfinamide mesylate( FCE-26742A (mesylate) )

Catalog No. M20790 CAS No. 202825-45-4

Ralfinamide mesylate is an orally available Na+ channel blocker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 181 In Stock
5MG 115 In Stock
10MG 180 In Stock
25MG 296 In Stock
50MG 384 In Stock
100MG 542 In Stock
200MG 728 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ralfinamide mesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ralfinamide mesylate is an orally available Na+ channel blocker.
  • Description
    Ralfinamide mesylate is an orally available Na+ channel blocker.
  • In Vitro
    ——
  • In Vivo
    Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain. Animal Model:81 adult male Sprague–Dawley male rats (260–460 g) Dosage:80 mg/kg (7 days preoperatively), 30 mg/kg, 60 mg/kg (postoperative)Administration:Oral gavage; twice daily; until postoperative day 42 Result:Suppressed neuropathic pain.
  • Synonyms
    FCE-26742A (mesylate)
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    202825-45-4
  • Formula Weight
    398.45
  • Molecular Formula
    C18H23FN2O5S?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O.CS(=O)(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liang X Yu G Su R . Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain[J]. European journal of pharmacology 2018 823:27-34.
molnova catalog
related products
  • Aneratrigine hydroch...

    Aneratrigine hydrochloride is a sodium channel protein type 9 subunit blocker that may be used for the prevention or treatment of sodium channel blocker-related diseases.

  • Camostat mesilate

    Camostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and matriptase.

  • Amiloride hydrochlor...

    A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.